Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
Franz–Josef Neumann(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Nicholas L. Mills(University of Edinburgh), William Parsonage(Queensland University of Technology), Simona Giampaoli, Christian W. Hamm(Justus-Liebig-Universität Gießen), Christoph Liebetrau(Kerckhoff Klinik), Barbara Thorand(Helmholtz Zentrum München), Raphael Twerenbold(German Centre for Cardiovascular Research), Philipp S. Wild(Johannes Gutenberg University Mainz), Martin Than(Christchurch Hospital), Niall Morris(Universität Hamburg), Evangelos Giannitsis(Heidelberg University), Licia Iacoviello(Istituto Neurologico Mediterraneo), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Frank Kee(Queen's University Belfast), Thomas Renné(Karolinska University Hospital), Tomas Jernberg(Karolinska Institutet), Nils A. Sörensen(Universität Hamburg), Stefan Söderberg(Umeå University), Atul Anand(British Heart Foundation), Hugh Tunstall‐Pedoe(University of Dundee), Hugo A. Katus(Heidelberg University), Richard Body(Manchester Academic Health Science Centre), Richard W. Troughton(Canterbury Health Laboratories), Ulf Ekelund(Lund University), Thomas Nestelberger(Universität Hamburg), Bertil Lindahl(Uppsala University), Francisco Ojeda(Universidad Complutense de Madrid), Louise Cullen(Royal Brisbane and Women's Hospital), John W. Pickering(Christchurch Hospital), Till Keller(Universität Hamburg), Susana Sans(Health Research Institute of the Balearic Islands), Veikko Salomaa(Finnish Institute for Health and Welfare), Matthias Mueller‐Hennessen(Universität Hamburg), Peter A. Kavsak(McMaster University), Andrew R. Chapman(Edinburgh Royal Infirmary), Patrick Badertscher(Universität Hamburg), Anoop Shah(Imperial College Healthcare NHS Trust), Jasper Boeddinghaus(University of Basel), Karl J. Lackner(Johannes Gutenberg University Mainz), Arash Mokhtari(Lund University), Rossana Borchini(University of Insubria), Ulf Landmesser(Deutsches Herzzentrum der Charité), Maurizio Ferrario(University of Insubria), Tommaso Gori(Johannes Gutenberg University Mainz), Annette Peters(Zimmer Biomet (Netherlands)), Jaimi Greenslade(Royal Brisbane and Women's Hospital), Andrew Worster(McMaster University), Thomas Münzel(Johannes Gutenberg University Mainz), Torben Jørgensen(University of Copenhagen)
Cited by 346
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k